Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Intermittent hypoxia and stem cell implants preserve breathing capacity in a rodent model of amyotrophic lateral sclerosis.

Nichols NL, Gowing G, Satriotomo I, Nashold LJ, Dale EA, Suzuki M, Avalos P, Mulcrone PL, McHugh J, Svendsen CN, Mitchell GS.

Am J Respir Crit Care Med. 2013 Mar 1;187(5):535-42. doi: 10.1164/rccm.201206-1072OC. Epub 2012 Dec 6.

2.

Mechanisms of Enhanced Phrenic Long-Term Facilitation in SOD1G93A Rats.

Nichols NL, Satriotomo I, Allen LL, Grebe AM, Mitchell GS.

J Neurosci. 2017 Jun 14;37(24):5834-5845. doi: 10.1523/JNEUROSCI.3680-16.2017. Epub 2017 May 12.

PMID:
28500219
3.

Acute intermittent hypoxia induced phrenic long-term facilitation despite increased SOD1 expression in a rat model of ALS.

Nichols NL, Satriotomo I, Harrigan DJ, Mitchell GS.

Exp Neurol. 2015 Nov;273:138-50. doi: 10.1016/j.expneurol.2015.08.011. Epub 2015 Aug 16. Erratum in: Exp Neurol. 2016 Apr;278:143.

4.

GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS.

Suzuki M, McHugh J, Tork C, Shelley B, Klein SM, Aebischer P, Svendsen CN.

PLoS One. 2007 Aug 1;2(8):e689.

5.

Respiratory function after selective respiratory motor neuron death from intrapleural CTB-saporin injections.

Nichols NL, Vinit S, Bauernschmidt L, Mitchell GS.

Exp Neurol. 2015 May;267:18-29. doi: 10.1016/j.expneurol.2014.11.011. Epub 2014 Dec 2.

6.

Degeneration of respiratory motor neurons in the SOD1 G93A transgenic rat model of ALS.

Lladó J, Haenggeli C, Pardo A, Wong V, Benson L, Coccia C, Rothstein JD, Shefner JM, Maragakis NJ.

Neurobiol Dis. 2006 Jan;21(1):110-8. Epub 2005 Aug 9.

PMID:
16084734
7.

GDNF delivery using human neural progenitor cells in a rat model of ALS.

Klein SM, Behrstock S, McHugh J, Hoffmann K, Wallace K, Suzuki M, Aebischer P, Svendsen CN.

Hum Gene Ther. 2005 Apr;16(4):509-21.

PMID:
15871682
8.

Peripheral hyperstimulation alters site of disease onset and course in SOD1 rats.

Lepore AC, Tolmie C, O'Donnell J, Wright MC, Dejea C, Rauck B, Hoke A, Ignagni AR, Onders RP, Maragakis NJ.

Neurobiol Dis. 2010 Sep;39(3):252-64. doi: 10.1016/j.nbd.2010.03.021. Epub 2010 Apr 8.

9.

GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.

Li K, Hala TJ, Seetharam S, Poulsen DJ, Wright MC, Lepore AC.

Neurobiol Dis. 2015 Jun;78:12-23. doi: 10.1016/j.nbd.2015.03.010. Epub 2015 Mar 25.

PMID:
25818008
11.

Phrenic long-term facilitation following intrapleural CTB-SAP-induced respiratory motor neuron death.

Nichols NL, Craig TA, Tanner MA.

Respir Physiol Neurobiol. 2017 Aug 16. pii: S1569-9048(17)30170-2. doi: 10.1016/j.resp.2017.08.003. [Epub ahead of print]

PMID:
28822818
12.

Quantitative assessment of integrated phrenic nerve activity.

Nichols NL, Mitchell GS.

Respir Physiol Neurobiol. 2016 Jun;226:81-6. doi: 10.1016/j.resp.2015.12.005. Epub 2015 Dec 24.

13.

Neither serotonin nor adenosine-dependent mechanisms preserve ventilatory capacity in ALS rats.

Nichols NL, Johnson RA, Satriotomo I, Mitchell GS.

Respir Physiol Neurobiol. 2014 Jun 15;197:19-28. doi: 10.1016/j.resp.2014.03.005. Epub 2014 Mar 28.

14.

Transient recovery in a rat model of familial amyotrophic lateral sclerosis after transplantation of motor neurons derived from mouse embryonic stem cells.

López-González R, Kunckles P, Velasco I.

Cell Transplant. 2009;18(10):1171-81. doi: 10.3727/096368909X12483162197123. Epub 2009 Aug 5.

PMID:
19660174
15.

Acute glial activation by stab injuries does not lead to overt damage or motor neuron degeneration in the G93A mutant SOD1 rat model of amyotrophic lateral sclerosis.

Suzuki M, Klein S, Wetzel EA, Meyer M, McHugh J, Tork C, Hayes A, Svendsen CN.

Exp Neurol. 2010 Feb;221(2):346-52. doi: 10.1016/j.expneurol.2009.12.004. Epub 2009 Dec 11.

16.

Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS.

Suzuki M, McHugh J, Tork C, Shelley B, Hayes A, Bellantuono I, Aebischer P, Svendsen CN.

Mol Ther. 2008 Dec;16(12):2002-10. doi: 10.1038/mt.2008.197. Epub 2008 Sep 16.

17.

Growth factor-expressing human neural progenitor cell grafts protect motor neurons but do not ameliorate motor performance and survival in ALS mice.

Park S, Kim HT, Yun S, Kim IS, Lee J, Lee IS, Park KI.

Exp Mol Med. 2009 Jul 31;41(7):487-500. doi: 10.3858/emm.2009.41.7.054.

18.

Predicting respiratory insufficiency in amyotrophic lateral sclerosis: the role of phrenic nerve studies.

Pinto S, Turkman A, Pinto A, Swash M, de Carvalho M.

Clin Neurophysiol. 2009 May;120(5):941-6. doi: 10.1016/j.clinph.2009.02.170. Epub 2009 Apr 1.

PMID:
19342290
19.

Human neural stem cell replacement therapy for amyotrophic lateral sclerosis by spinal transplantation.

Hefferan MP, Galik J, Kakinohana O, Sekerkova G, Santucci C, Marsala S, Navarro R, Hruska-Plochan M, Johe K, Feldman E, Cleveland DW, Marsala M.

PLoS One. 2012;7(8):e42614. doi: 10.1371/journal.pone.0042614. Epub 2012 Aug 20.

20.

Modulation of astrocytic mitochondrial function by dichloroacetate improves survival and motor performance in inherited amyotrophic lateral sclerosis.

Miquel E, Cassina A, Martínez-Palma L, Bolatto C, Trías E, Gandelman M, Radi R, Barbeito L, Cassina P.

PLoS One. 2012;7(4):e34776. doi: 10.1371/journal.pone.0034776. Epub 2012 Apr 3.

Supplemental Content

Support Center